Didn't find the company you were looking for? Our full system contains all Danish companies, including comprehensive credit risk reports. Register here to get started.
You can find text and video tutorials here that explain how to use our system.
Selskabet af 23. december 2021 A/S
Credit rating
Company information
21Manufacture of basic pharmaceutical products and pharmaceutical preparations
About the company
Selskabet af 23. december 2021 A/S (CVR number: 25881435) is a company from KØBENHAVN. The company recorded a gross profit of -15581.8 kDKK in 2020. The operating profit was -22.8 mDKK, while net earnings were -24.3 mDKK. The profitability of the company measured by Return on Assets (ROA) was -23.9 %, which can be considered poor and Return on Equity (ROE) was -45.7 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -4.5 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Selskabet af 23. december 2021 A/S's liquidity measured by quick ratio was 0.6 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| Volume | |||||
| Net sales | 684.00 | 163.00 | |||
| Gross profit | -18 682.00 | -17 323.00 | -16 784.43 | -21 794.22 | -15 581.85 |
| EBIT | -27 468.00 | -25 689.00 | -27 493.96 | -29 392.20 | -22 765.94 |
| Net earnings | -22 825.00 | -22 258.00 | -24 458.33 | -26 673.58 | -24 282.51 |
| Shareholders equity total | 93 648.00 | 71 326.00 | 47 391.75 | 20 756.53 | -4 010.96 |
| Balance sheet total (assets) | 108 778.00 | 105 562.00 | 101 245.08 | 94 844.61 | 85 565.38 |
| Net debt | 9 532.00 | 28 612.00 | 49 466.06 | 66 280.15 | 78 016.92 |
| Profitability | |||||
| EBIT-% | -4015.8 % | -15760.1 % | |||
| ROA | -25.3 % | -23.8 % | -26.5 % | -29.8 % | -23.9 % |
| ROE | -24.4 % | -27.0 % | -41.2 % | -78.3 % | -45.7 % |
| ROI | -26.0 % | -24.4 % | -27.2 % | -31.5 % | -26.5 % |
| Economic value added (EVA) | -22 583.28 | -26 774.89 | -25 898.10 | -26 709.40 | -21 466.47 |
| Solvency | |||||
| Equity ratio | 86.1 % | 67.6 % | 46.8 % | 21.9 % | -4.5 % |
| Gearing | 12.8 % | 45.5 % | 106.0 % | 324.7 % | -1953.0 % |
| Relative net indebtedness % | 1855.8 % | 18646.6 % | |||
| Liquidity | |||||
| Quick ratio | 0.7 | 2.6 | 1.1 | 1.0 | 0.6 |
| Current ratio | 0.7 | 2.6 | 1.8 | 1.5 | 1.0 |
| Cash and cash equivalents | 2 436.00 | 3 842.00 | 790.11 | 1 109.14 | 315.49 |
| Capital use efficiency | |||||
| Trade debtors turnover (days) | 35.8 | ||||
| Net working capital % | -764.9 % | 5183.4 % | |||
| Credit risk | |||||
| Credit rating | BB | BB | BB | BB | B |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
... and more!
No registration needed.